Literature DB >> 18446925

Drug subsidy could help Tanzania tackle malaria.

Udani Samarasekera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446925     DOI: 10.1016/s0140-6736(08)60611-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.

Authors:  Justin M Cohen; Oliver Sabot; Kate Sabot; Megumi Gordon; Isaac Gross; David Bishop; Moses Odhiambo; Yahya Ipuge; Lorrayne Ward; Alex Mwita; Catherine Goodman
Journal:  BMC Health Serv Res       Date:  2010-07-02       Impact factor: 2.655

Review 2.  Towards subsidized malaria rapid diagnostic tests. Lessons learned from programmes to subsidise artemisinin-based combination therapies in the private sector: a review.

Authors:  Cristina Lussiana
Journal:  Health Policy Plan       Date:  2015-04-09       Impact factor: 3.344

Review 3.  Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings.

Authors:  Adam Bennett; Anton L V Avanceña; Jennifer Wegbreit; Chris Cotter; Kathryn Roberts; Roly Gosling
Journal:  Malar J       Date:  2017-06-14       Impact factor: 2.979

4.  Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021.

Authors:  Dickson Pius Wande; Raphael Zozimus Sangeda; Prosper Tibalinda; Innocent Kairuki Mutta; Sonia Mkumbwa; Adonis Bitegeko; Eliangiringa Kaale
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

5.  Access to malaria treatment in young children of rural Burkina Faso.

Authors:  Maike Tipke; Valérie R Louis; Maurice Yé; Manuela De Allegri; Claudia Beiersmann; Ali Sié; Olaf Mueller; Albrecht Jahn
Journal:  Malar J       Date:  2009-11-24       Impact factor: 2.979

6.  Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial.

Authors:  Boubacar Coulibaly; Augustin Zoungrana; Frank P Mockenhaupt; R Heiner Schirmer; Christina Klose; Ulrich Mansmann; Peter E Meissner; Olaf Müller
Journal:  PLoS One       Date:  2009-05-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.